Enanta Pharmaceuticals | ENTA - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Amgen USD 3.86B 1.28B 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 5.16B 510M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Merck USD -1.54B 7.84B 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06